ESMERALDA GONZALES: Open Payments
NPI 1174061436 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$326 in 16 payments from 8 companies in 2025. Trend: 2023 $114 · 2024 $242 · 2025 $326
Food & beverage: $326
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 3 | $77 |
| Averitas Pharma Inc. | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| Lilly USA, LLC | 2 | $36 |
| Exact Sciences Corporation | 2 | $31 |
| Abbott Laboratories | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: QUTENZA, Dexcom G6 Transmitter, CAPVAXIVE, MOUNJARO, AIRSUPRA, Cologuard Collection Kit, DEXCOM G7 GSS (161), FREESTYLE LIBRE 3.
Industry payments across FL — which companies pay providers there.
